Daily Scientific Program

The approved presentation materials in PDF version are now available to view and download from October 24 (Wed) until November 16 (Fri), 2018. Please click the PDF button next to lecture title.

Day 1, Oct. 5 (Fri)

 

Place: Halla Hall, 3F, ICC Jeju

Pre-congress workshop 1

Practical Implementation of Ketogenic Therapy I 13:00-15:10

Chair(s)Eric Kossoff (USA), Christina Bergqvist (USA)
[13:00-13:40]  Introduction to the KDPCW 1-1Eric Kossoff (USA)
[13:40-14:20]  Overview of the mechanisms of the KDJong Rho (Canada)
[14:20-15:00]  Indication of the KD (epilepsy, autism, brain cancer and other neurologic disorders) Ingrid Scheffer (Australia)
[15:00-15:10]  Q&A

Break

15:10-15:30

Place: Halla Hall, 3F, ICC Jeju

Pre-congress workshop 2

Practical Implementation of Ketogenic Therapy II 15:30-17:20

Chair(s)Hoon-Chul Kang (Korea), Beth Zupec-Kania (USA)
[15:30-16:00]  Diverse ketogenic therapies (Classic, Atkins, Modified Atkins, and Low glycemic index treatment)PCW 2-1Hoon-Chul Kang (Korea)
[16:00-16:40]  Practical dietary procedure for ketogenic therapies PCW 2-2Beth Zupec-Kania (USA)
Meredith Hornbuckle (USA)
Lisa Vanatta (USA)
[16:40-17:10]  Management and prevention for complications of the ketogenic therapiesJoo Hee Seo (USA)
[17:10-17:20]  Q&A
Place: Oceanview, 5F, ICC Jeju

Welcome reception

18:30-20:30

[18:30-20:30]  Welcome reception

Day 2, Oct. 6 (Sat)

 

Place: Halla Hall, 3F, ICC Jeju

Welcome address

08:00-08:15

[08:00-08:15]  Welcome addressHeung Dong Kim (Korea)
Jong Rho (Canada)
Jim Abrahams (USA)
Place: Halla Hall, 3F, ICC Jeju

Special lecture 1

Revisiting the KD and related therapies in the modern era08:15-08:45

Chair(s)Ingrid Scheffer (Australia)
[08:15-08:45]  Revisiting the KD and related therapies in the modern eraSL 1-1Heung Dong Kim (Korea)
Place: Halla Hall, 3F, ICC Jeju

Main session 1

Dietary therapy for epilepsy: Recent update08:45-10:25

Chair(s)Heung Dong Kim (Korea), Ingrid Scheffer (Australia)
[08:45-09:10]  KD therapy and epilepsy geneticsIngrid Scheffer (Australia)
[09:10-09:35]  Impaired signaling pathways in epilepsies and other diseasesAmy Brooks-Kayal (USA)
[09:35-09:55]  Revised recommendation of KD from international consensusMS 1-3Eric Kossoff (USA)
[09:55-10:15]  Expanding KD therapy from infancy to adultMS 1-4Helen Cross (UK)
[10:15-10:25]  Discussion

Coffee Break

10:25-10:40

Place: Halla Hall, 3F, ICC Jeju

Parallel session 1

KD therapy in epilepsy syndromes 10:40-12:00

Chair(s)Tae-Sung Ko (Korea), Hirokazu Oguni (Japan)
[10:40-11:00]  Early onset epileptic encephalopathy (EIEE, WS, etc)PS 1-1Douglas Nordli (USA)
[11:00-11:20]  Dravet syndrome and use of ketogenic dietsChristina Bergqvist (USA)
[11:20-11:40]  Ketogenic diet therapy in epilepsy with myoclonic-atonic seizures (EMA)PS 1-3Hirokazu Oguni (Japan)
[11:40-12:00]  Structural epilepsyDa Eun Jung (Korea)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 2

Methods for improving KD compliance10:40-12:00

Chair(s)Sang Ook Nam (Korea), Janak Nathan (India)
[10:40-11:00]  Premade keto meals, snacks, supplements, and formulasPavel Klein (USA)
[11:00-11:20]  Strategies for providing patient access to diet clinics and dietitian supportPS 2-2Janak Nathan (India)
[11:20-11:40]  Psychological strategies to improve compliance Se Hee Kim (Korea)
[11:40-12:00]  Modified diets for adolescents and adults with intractable epilepsy PS 2-4Antoaneta Balabanov (USA)

Lunch

12:00-13:30

Place: Halla Hall, 3F, ICC Jeju

Main session 2

Delving into the details of ketogenic nutrition 13:30-15:20

Chair(s)Beth Zupec-Kania (USA), Songmi Lee (Korea)
[13:30-13:50]  An overview of micronutrients and their potential for insufficiency in KD therapiesHeidi Pfeifer (USA)
[13:50-14:10]  Supplementing with nutrients that may benefit KD therapy; vitamin D, electrolytes, carnitine and othersMS 2-2Denise Potter (USA)
[14:10-14:30]  Fats and oils contribute important nutrients to ketogenic therapiesMS 2-3Kelly Roehl (USA)
[14:30-14:50]  Constipation, renal stones and acute illnesses on KDMS 2-4Eunjoo Lee (Korea)
[14:50-15:10]  Evidence of KD in adultMS 2-5Mackenzie Cervenka (USA)
[15:10-15:20]  Discussion
Place: Halla Hall, 4F, ICC Jeju

Coffee Break

15:20-15:40

Place: Halla Hall, 3F, ICC Jeju

Parallel session 3

Individualized diet therapy - Choosing the right KD therapy for the right patient 15:40-17:20

Chair(s)Hoon-Chul Kang (Korea), Mackenzie Cervenka (USA)
[15:40-16:00]  Use of the KD therapy in neonatesPS 3-1Ara Ko (Korea)
[16:00-16:20]  LGIT for Angelman syndromeHeidi Pfeifer (USA)
[16:20-16:40]  KD for Rett syndromePS 3-3Pi-Lien Hung (Taiwan)
[16:40-17:00]  KD therapy for mitochondrial disorders Young Mock Lee (Korea)
[17:00-17:20]  Emerging paradigms in treatment of childhood epilepsyPS 3-5Sheffali Gulati (India)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 4

Basic research for testing KD therapies15:40-17:20

Chair(s)Robin Williams (UK), Byung Ho Cha (Korea)
[15:40-16:00]  Understanding KD with rodent epilepsy modelsPS 4-1Do-Young Kim (USA)
[16:00-16:20]  Non-mammalian models move our understanding of ketogenic mechanismsPS 4-2Robin Williams (UK)
[16:20-16:40]  Cellular insights into KD therapiesPS 4-3Simon Heales (UK)
[16:40-17:00]  Fatty acid for glioblastoma bioenergeticsPS 4-4Karin Borges (Australia)
[17:00-17:20]  Optogenetic approachesEunji Cheong (Korea)

Day 3, Oct. 7 (Sun)

 

Place: Halla Hall, 3F, ICC Jeju

Special lecture 2

Basic mechanism of KD action08:00-08:30

Chair(s)Douglas Nordli (USA)
[08:00-08:30]  Basic mechanism of KD actionJong Rho (Canada)
Place: Halla Hall, 3F, ICC Jeju

Main session 3

Recent and future of clinical trials on KD in the epilepsy field08:30-10:10

Chair(s)Stéphane Auvin (France), Huei-Shyong Wang (Taiwan)
[08:30-09:00]  Ketogenic diets in inborn disorders of metabolism - new ways of thinkingMS 3-1Sabine Scholl-Bürgi (Austria)
[09:00-09:30]  Clinical trial design for KD therapies - promoting international collaborationMS 3-2Ki-Joong Kim (Korea)
[09:30-10:00]  Designing a KD study with gut microbiotaMS 3-3Sae Hun Kim (Korea)
[10:00-10:10]  Discussion

Coffee Break

10:10-10:30

Place: Halla Hall, 3F, ICC Jeju

Parallel session 5

Brain-Gut inter-relationships10:30-12:10

Chair(s)Jong Rho (Canada), Derrick Chan Wei Shih (Singapore)
[10:30-10:55]  What is the impact of the microbiome on brain cellular metabolism?Jong Rho (Canada)
[10:55-11:20]  A glimpse of microbiome studies related to the host behavior patternsIn-Geol Choi (Korea)
[11:20-11:45]  Potential role of microbiota in immunity and epilepsyDerrick Chan Wei Shih (Singapore)
[11:45-12:10]  Effects of the KD in experimental models of neurological diseasePS 5-4Jane Shearer (Canada)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 6

KD therapies and sleep10:30-12:10

Chair(s)Kristina Simeone (USA), Kyu Young Chae (Korea)
[10:30-10:55]  KD treatment and sleep in epilepsyPS 6-1Ming-Yu Chang (Taiwan)
[10:55-11:20]  Mediterranean diet and sleepPS 6-2Walter Currenti (Italy)
[11:20-11:45]  Intermittent fasting and sleepHyang Woon Lee (Korea)
[11:45-12:10]  KD treatment and sudden unexpected death in epilepsyKristina Simeone (USA)

Lunch

12:10-13:30

Place: Halla Hall, 3F, ICC Jeju

Main session 4

KD for status epilepticus13:30-15:20

Chair(s)Eric Kossoff (USA), Jeehun Lee (Korea)
[13:30-13:55]  KD therapy for super-refractory status epilepticusMS 4-1Mackenzie Cervenka (USA)
[13:55-14:20]  Pearls and pitfalls for emergency KD use in pediatricsMS 4-2Courtney Haney (USA)
[14:20-14:45]  Parenteral vs. enteral ketosis induction in super-refractory status epilepticusMS 4-3Sirinuch Chomtho (Thailand)
[14:45-15:10]  Favorable factors for KD response in super-refractory status epilepticusJeehun Lee (Korea)
[15:10-15:20]  Discussion

Coffee Break

15:20-15:40

Place: Halla Hall, 3F, ICC Jeju

Parallel session 7

Glut1-deficiency and KD: past, presence and future15:40-17:20

Chair(s)Jong Hee Chae (Korea), Joerg Klepper (Germany)
[15:40-16:00]  Clinical spectrum and genetic mechanism of GLUT1-DSPS 7-1Yasushi Ito (Japan)
[16:00-16:20]  Have we done wrong? Long term follow-up of cardiovascular risk factors in Glut1 Deficiency treated with KD therapiesNicole Heussinger (Germany)
[16:20-16:40]  Use and potential of the modified Atkins Diet in Glut1DRita Yu (Korea)
[16:40-17:00]  The future therapy of Glut1D; triheptanoin and ketoesters PS 7-4Hoon-Chul Kang (Korea)
[17:00-17:20]  Glut1D and KD : where will we be in 2025?Joerg Klepper (Germany)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 8

Basic research for KD therapies15:40-17:20

Chair(s)Sookyong Koh (USA), Ji Eun Choi (Korea)
[15:40-16:05]  Regulation of systemic inflammation by metabolic substratesEmily Goldberg (USA)
[16:05-16:30]  Anti-inflammatory targets for epilepsy: drugs vs. dietsPS 8-2Sookyong Koh (USA)
[16:30-16:55]  Role of KD therapy in autoimmune encephalitis PS 8-3I-Jun Chou (Taiwan)
[16:55-17:20]  Anti‐inflammatory effects of a ketogenic diet: implications for new indicationsPS 8-4Stéphane Auvin (France)
Place: Lobby, 3F, ICC Jeju

Poster rounding and discussion

18:00-20:00

Day 4, Oct. 8 (Mon)

 

Place: Halla Hall, 3F, ICC Jeju

Special lecture 3

Disease-modifying, anti-epileptogenic, and neuroprotective effects of the KD: clinical implications08:00-08:30

Chair(s)Manisha Patel (USA)
[08:00-08:30]  Disease-modifying, anti-epileptogenic, and neuroprotective effects of the KD: clinical implicationsSL 3-1Michael Wong (USA)
Place: Halla Hall, 3F, ICC Jeju

Main session 5

Identifying signaling pathways targeted by KD : first steps towards precision medicine 08:30-10:10

Chair(s)Manisha Patel (USA), Michael Wong (USA)
[08:30-09:00]  Metabolomic identification of altered signaling pathways by KDManisha Patel (USA)
[09:00-09:30]  The role of PPARgamma in Epilepsy and KD efficacyTim Simeone (USA)
[09:30-10:00]  Metabolic dysfunction underlying autism spectrum disorder and potential treatment approachesSusan Masino (USA)
[10:00-10:10]  Discussion

Coffee Break

10:10-10:30

Place: Halla Hall, 3F, ICC Jeju

Parallel session 9

Expanding the use of the KD therapy 10:30-12:10

Chair(s)Sookyong Koh (USA), Sang Ook Nam (Korea)
[10:30-10:50]  Modified diets for better compliance, including non-traditional usePS 9-1Bobbie Henry-Barron (USA)
[10:50-11:10]  KD therapy for autism spectrum disorder Ning Cheng (Canada)
[11:10-11:30]  Effects of ketogenic diet therapy on the neurobehavioral development in children with global developmental delaysPS 9-3Dengna Zhu (China)
[11:30-11:50]  KD therapy after resected pancreatic cancer Chang Moo Kang (Korea)
[11:50-12:10]  KD therapy for brainstem tumorsPS 9-5Kuang-Lin Lin (Taiwan)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 10

Expansion to Asia: bringing ketogenic therapies to our region I10:30-12:10

Chair(s)Teik Beng Khoo (Malaysia), Yuwu Jiang (China)
[10:30-10:50]  Multi-center control trial for KD treating West syndrome in Chinese patients PS 10-1Yuwu Jiang (China)
[10:50-11:10]  China: helping build centers for excellence PS 10-2Jianxiang Liao (China)
[11:10-11:30]  Indian perspectivePS 10-3Janak Nathan (India)
Suvasini Sharma (India)
[11:30-11:50]  Experience of KD: Malaysian perspectivePS 10-4Teik Beng Khoo (Malyasia)
[11:50-12:10]  Experience with the KD in the PhilippinesPS 10-5Benilda Sanchez-Gan (Philippines)

Lunch

12:10-13:30

Place: Halla Hall, 3F, ICC Jeju

Parallel session 11

Diverse targets with mTOR pathway disorders for diet therapies13:30-15:00

Chair(s)Michael Wong (USA), Hoon-Chul Kang (Korea)
[13:30-14:00]  The mTOR pathway as a target for dietary therapy in epilepsy and related disordersPS 11-1Michael Wong (USA)
[14:00-14:30]  GATOR complex genes as a potential therapeutic targets of diet therapyStéphanie Baulac (France)
[14:30-15:00]  Diet therapy for the management of epilepsy associated to toropathiesPS 11-3Hoon-Chul Kang (Korea)
Place: Samda Hall, 3F, ICC Jeju

Parallel session 12

Expansion to Asia: bringing ketogenic therapies to our region II 13:30-15:00

Chair(s)Shahnaz Ibrahim (Pakistan), Soon Hak Kwon (Korea)
[13:30-13:45]  Experience of the KD: the Parkistani perspectiveShahnaz Ibrahim (Pakistan)
[13:45-14:00]  Experience of the KD from Saudi ArabiaPS 12-2Adel Mahmoud (Saudi Arabia)
[14:00-14:15]  Experience from South AfricaPS 12-3Amanda Rusch (South Africa)
[14:15-14:30]  KD Experience in Thailand PS 12-4Krisnachai Chomtho (Thailand)
[14:30-14:45]  Experience of the KD: an Iranian perspectivePS 12-5Parvaneh Karimzadeh (Iran)
[14:45-15:00]  Discussion

Coffee Break

15:00-15:20

Place: Halla Hall, 3F, ICC Jeju

Hand over session

15:20-15:50

Chair(s)Jong Rho (Canada), Helen Cross (UK)
[15:20-15:50]  Hand over sessionHeung Dong Kim (Korea)
Helen Cross (UK)
Place: Committee Room, 3F, ICC Jeju

Regional committee meeting

16:30-17:30

Place: Aldre Garden, Seaes Hotel Jeju

Gala dinner

19:00-21:00

Day 5, Oct. 9 (Tue)

 

Simultaneous interpretation between Korean and English will be provided for Family support group session &
     The keto workshop for dietitians
Place: Samda Hall, 3F, ICC Jeju

Family support group

Preparing a family for the KD therapy09:00-12:00

Chair(s)Sookyong Koh (USA), Beth Zupec-Kania (USA)
[09:00-09:30]  Caring for a child with epilepsyFSG 1-1Sookyong Koh (USA)
[09:30-10:00]  Bringing parents to the tableFSG 1-2Natasha Schoeler (UK)
[10:00-10:30]  Nursing know-how in diet complianceBrialie Forster (Australia)
[10:30-11:00]  How parent support groups may helpFSG 1-4Sue Wood (UK)
[11:00-11:30]  Support from Charlie FoundationFSG 1-5Beth Zupec-Kania (USA)
[11:30-12:00]  Psychological support for family with intractable epilepsyFSG 1-6Soyong Eom (Korea)
Place: Halla Hall, 3F, ICC Jeju

The keto workshop for dietitians

KD meal planning strategies 09:00-12:00

Chair(s)Heidi Pfeifer (USA), Yoo kyoung Park (Korea)
[09:00-09:30]  Initiation of the KDKW 1-1Jennifer Fabe (Canada)
[09:30-10:00]  Monitoring and supplementation of the KDHeidi Pfeifer (USA)
[10:00-10:30]  Newly developed recipe for modified ketogenic dietEunjeung Choi (Korea)
[10:30-11:00]  The potential use of a ketogenic diet as an adjuvant anti-cancer therapy Songmi Lee (Korea)
[11:00-11:30]  Mobile apps for KD meal planningKW 1-5Eunjoo Lee (Korea)
[11:30-12:00]  Application of cooking oils for the KD recipeKW 1-6Hsiu-Fen Lee (Taiwan)
Place: Halla Hall, 3F, ICC Jeju

Resource Sharing Session

Keto Demonstrations and Sharing Session12:10-13:40